Ligand validation:4LVC

ADN: ADENOSINE

ADN is a Ligand Of Interest in 4LVC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LVC_ADN_B_501	36%	28%	0.206	0.899	1.3	1.6	3	3	1	0	100%	0.7
4LVC_ADN_C_501	24%	21%	0.222	0.854	1.46	1.87	3	4	1	0	100%	0.7
4LVC_ADN_A_501	23%	21%	0.235	0.861	1.32	1.94	2	6	1	0	100%	0.7
6EXI_ADN_A_503	97%	36%	0.063	0.978	1	1.49	2	2	0	0	100%	1
5M66_ADN_D_502	90%	25%	0.084	0.968	1.12	1.92	2	5	3	0	100%	1
5M5K_ADN_A_502	90%	30%	0.091	0.975	0.98	1.77	1	3	2	0	100%	1
2ZBU_ADN_C_503	100%	25%	0.021	0.995	1.3	1.74	2	2	0	0	100%	1
4KAN_ADN_B_401	100%	24%	0.033	0.987	0.82	2.28	-	3	0	0	100%	1
5A1I_ADN_A_407	99%	50%	0.051	0.989	0.61	1.29	-	3	0	0	100%	0.5
3OND_ADN_B_507	99%	36%	0.049	0.983	1.21	1.3	1	1	0	0	100%	1
1VHW_ADN_E_252	99%	23%	0.048	0.978	1.55	1.6	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.